What is the recommended Hepatitis A vaccine dose schedule for an adult or adolescent with immunity to Hepatitis B and no evidence of Hepatitis C infection?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 8, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hepatitis A Vaccine Dosing Schedule

For an adult with immunity to hepatitis B (anti-HBs positive) and no hepatitis C infection, administer the standard 2-dose hepatitis A vaccine series: either Havrix at 0 and 6-12 months or Vaqta at 0 and 6-18 months. 1, 2

Standard Dosing Regimens

The two single-antigen hepatitis A vaccines available have the following schedules:

  • Havrix (adults): 1.0 mL (1440 ELISA units) intramuscularly, followed by a second 1.0 mL dose administered 6-12 months later 2, 3
  • Vaqta (adults): 1.0 mL (50 units) intramuscularly, followed by a booster dose 6-12 months later 3

Both vaccines should be administered in the deltoid muscle in adults 2

Why Not Twinrix?

Do not use Twinrix (combination hepatitis A and B vaccine) in this patient. 4 Since your patient already has documented immunity to hepatitis B (anti-HBs 30.14 IU/mL, which is above the protective threshold of 10 mIU/mL), using Twinrix would expose them to unnecessary hepatitis B antigen without clinical benefit 4

Twinrix is specifically reserved for patients who need protection against both hepatitis A and hepatitis B viruses simultaneously 1, 4

Clinical Context for Hepatitis A Vaccination

Consider hepatitis A vaccination for adults with any of the following indications 1:

  • Travel-related: Persons traveling to or working in countries with high or intermediate hepatitis A endemicity 1
  • Behavioral risk factors: Men who have sex with men, persons who use injection or noninjection illicit drugs 1
  • Occupational exposure: Persons working with HAV-infected primates or with HAV in research laboratory settings 1
  • Medical conditions: Persons with chronic liver disease, persons who receive clotting factor concentrates 1
  • Homelessness: Added as a routine indication in 2018 1
  • General protection: Any person seeking protection from hepatitis A without a specific risk factor 5

Important Administration Details

  • Timing of protection: Protective antibody levels are reliably present by 4 weeks after the first dose and may afford protection as soon as 2 weeks after immunization 1
  • Route: Administer intramuscularly only; do not give intravenously, intradermally, or subcutaneously 2
  • Interchangeability: If the vaccine series is started with one brand, it is preferable to complete with the same brand, but the vaccines are interchangeable if necessary 1

Common Pitfalls to Avoid

  • Do not use Twinrix simply because it contains hepatitis A vaccine—this patient does not need hepatitis B vaccination 4
  • Do not administer in the gluteal region, as this may result in suboptimal immune response 2
  • Do not delay the second dose beyond 18 months, though some flexibility exists in the 6-18 month window 1, 2
  • Do not routinely perform pre-vaccination serologic testing for hepatitis A antibodies in young adults, as it is not cost-effective in most populations 1, 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hepatitis A vaccine: ready for prime time.

Obstetrics and gynecology, 1998

Guideline

Hepatitis B Vaccination Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Prevention of Hepatitis A Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices, 2020.

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, 2020

Related Questions

What are the recommended vaccines for hepatitis?
What if a parent has concerns about a child receiving a hepatitis A vaccine, such as Havrix (inactivated hepatitis A vaccine) or Vaqta (inactivated hepatitis A vaccine)?
After how long can a patient with acute hepatitis A be vaccinated against hepatitis A?
What is the recommended schedule and protocol for Hepatitis A (Hep A) vaccination?
What are the most appropriate recommendations for a 19-year-old male with negative Hepatitis A (Hepatitis A) IgG antibody, positive Hepatitis B (Hepatitis B) surface antibody, undetectable Hepatitis C virus (HCV) RNA, and oropharyngeal Neisseria gonorrhoeae (N. gonorrhoeae) infection?
What is the clinical significance of the relationship between Tricuspid Annular Plane Systolic Excursion (TAPSE) and Pulmonary Vascular Resistance (PVR) in patients with Acute Respiratory Distress Syndrome (ARDS)?
What is the best course of action for a male adult patient presenting with left lateral back pain, hematuria, and nephrolithiasis, with a history of potential diabetes?
What is the best approach to manage insomnia in an elderly patient with Alzheimer's dementia who stays up for 24 hours, potentially exacerbating cognitive decline, and would 3mg of melatonin (PRN) be a suitable treatment option?
What is the management of retinitis in a child or young adult with latent Subacute Sclerosing Panencephalitis (SSPE) and a history of measles infection or vaccination?
Would a patient developing Subacute Sclerosing Panencephalitis (SSPE) after having measles likely present with retinitis one year post-measles infection?
What are the next steps for a patient with a history of breast cancer who has undergone a failed sentinel lymph node (SLN) biopsy?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.